About

Harveer Dev is a urological surgeon and researcher whose work centers on improving oncological outcomes in prostate and testicular cancer surgery, with a particular focus on robotic-assisted techniques. His most cited study (91 citations) established that the length and location of positive surgical margins after robotic prostatectomy are critical predictors of biochemical recurrence, directly linking surgeon skill and experience to patient prognosis. Dev further demonstrated that these margin characteristics differ significantly between open and robotic approaches, providing actionable insights for surgical planning. His comparative study of post-chemotherapy retroperitoneal lymph node dissections (35 citations) advanced understanding of robotic applications in testicular cancer management. Notably, Dev also pioneered quality assessment methods for biobanking prostate tissue during robotic surgery (32 citations), showing that RNA quality can be preserved despite longer ischemia times—a methodological contribution that enabled downstream molecular studies. His detailed analysis of learning curves for novice robotic surgeons (26 citations) remains a practical guide for training programs. Through these contributions, Dev has helped define best practices for achieving optimal cancer control while advancing the evidence base for minimally invasive urological oncology.

Research Focus

Key Achievements

8
H-Index
8
Papers
277
Total Citations
35
Avg Citations/Paper
🏆 Most Cited Paper
Surgical margin length and location affect recurrence rates after robotic prostatectomy
91 citations · 2014
📈 Most Prolific Year: 2011 (4 Papers)
🤝 Key Collaborators: 49
🏛 Institutions: Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cornell University, St. John's College of Nursing, NewYork–Presbyterian Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago